| Patrick F Timmins Iii, MD | |
|
319 S Manning Blvd, Suite 301, Albany, NY 12208-1742 | |
| (518) 458-1390 | |
| (518) 459-3271 |
| Full Name | Patrick F Timmins Iii |
|---|---|
| Gender | Male |
| Speciality | Gynecological Oncology |
| Experience | 32 Years |
| Location | 319 S Manning Blvd, Albany, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942297080 | NPI | - | NPPES |
| 01678817 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 202700 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Peter's Hospital | Albany, NY | Hospital |
| Vassar Brothers Medical Center | Poughkeepsie, NY | Hospital |
| Samaritan Hospital | Troy, NY | Hospital |
| Albany Medical Center Hospital | Albany, NY | Hospital |
| Northern Dutchess Hospital | Rhinebeck, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nuvance Health Medical Practice, Pc | 1658468442 | 441 |
| Women's Cancer Care Associates, Llc | 9436259454 | 6 |
News Archive
Population-based screening with full-field digital mammography (FFDM) is associated with lower recall and biopsy rates than screen film mammography (SFM), suggesting that FFDM may reduce the number of diagnostic workups and biopsies that do not lead to diagnosis of breast cancer, according to a new study published online in the journal Radiology.
A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.
The Allen Institute for Cell Science today launched the first predictive and comprehensive, 3D model of a live human cell, the Allen Integrated Cell.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
› Verified 9 days ago
| Entity Name | Women's Cancer Care Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689713067 PECOS PAC ID: 9436259454 Enrollment ID: O20070705000213 |
News Archive
Population-based screening with full-field digital mammography (FFDM) is associated with lower recall and biopsy rates than screen film mammography (SFM), suggesting that FFDM may reduce the number of diagnostic workups and biopsies that do not lead to diagnosis of breast cancer, according to a new study published online in the journal Radiology.
A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.
The Allen Institute for Cell Science today launched the first predictive and comprehensive, 3D model of a live human cell, the Allen Integrated Cell.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
› Verified 9 days ago
| Entity Name | Nuvance Health Medical Practice, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437358033 PECOS PAC ID: 1658468442 Enrollment ID: O20071025000436 |
News Archive
Population-based screening with full-field digital mammography (FFDM) is associated with lower recall and biopsy rates than screen film mammography (SFM), suggesting that FFDM may reduce the number of diagnostic workups and biopsies that do not lead to diagnosis of breast cancer, according to a new study published online in the journal Radiology.
A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.
The Allen Institute for Cell Science today launched the first predictive and comprehensive, 3D model of a live human cell, the Allen Integrated Cell.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patrick F Timmins Iii, MD 319 S Manning Blvd, Suite 301, Albany, NY 12208-1742 Ph: (518) 458-1390 | Patrick F Timmins Iii, MD 319 S Manning Blvd, Suite 301, Albany, NY 12208-1742 Ph: (518) 458-1390 |
News Archive
Population-based screening with full-field digital mammography (FFDM) is associated with lower recall and biopsy rates than screen film mammography (SFM), suggesting that FFDM may reduce the number of diagnostic workups and biopsies that do not lead to diagnosis of breast cancer, according to a new study published online in the journal Radiology.
A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.
The Allen Institute for Cell Science today launched the first predictive and comprehensive, 3D model of a live human cell, the Allen Integrated Cell.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
› Verified 9 days ago
Dr. Cheryl B Burack, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 62 Hackett Blvd, Albany, NY 12209 Phone: 518-465-7062 Fax: 518-449-1378 | |
Alexis Joanna Disilvestro, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 400 Patroon Creek Blvd Ste 102, Albany, NY 12206 Phone: 518-445-4325 | |
Benjamin Margolis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 391 Myrtle Ave Ste 200, Albany, NY 12208 Phone: 518-262-4942 Fax: 518-262-5291 | |
Corinne Mcleod, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 391 Myrtle Ave Ste 2, Albany, NY 12208 Phone: 518-264-4942 | |
Caitlin Wood Parrott, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 400 Patroon Creek Blvd Ste 102, Albany, NY 12206 Phone: 518-445-4320 Fax: 518-475-7050 | |
Dr. Ryan Dennis Cuff, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 400 Patroon Creek Blvd Ste 102, Albany, NY 12206 Phone: 518-445-4325 | |
Peter Namkoong, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1365 Washington Ave, Suite 201, Albany, NY 12206 Phone: 518-489-4446 Fax: 518-489-4448 |